These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33355520)

  • 1. Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress.
    Hossain MJ; Rahman SMA
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1009-1027. PubMed ID: 33355520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
    Debnath SK; Debnath M; Srivastava R; Omri A
    Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.
    Taibe NS; Kord MA; Badawy MA; Shytaj IL; Elhefnawi MM
    Ther Adv Respir Dis; 2022; 16():17534666221132736. PubMed ID: 36282077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing anticancer drugs for the management of COVID-19.
    El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
    Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in the repurposing of drugs/molecules for the management of COVID-19.
    Sharma D; Kunamneni A
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):889-897. PubMed ID: 33270490
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug repurposing: new strategies for addressing COVID-19 outbreak.
    Shende P; Khanolkar B; Gaud RS
    Expert Rev Anti Infect Ther; 2021 Jun; 19(6):689-706. PubMed ID: 33183102
    [No Abstract]   [Full Text] [Related]  

  • 8. Repurposing drugs for the management of COVID-19.
    Cusinato J; Cau Y; Calvani AM; Mori M
    Expert Opin Ther Pat; 2021 Apr; 31(4):295-307. PubMed ID: 33283567
    [No Abstract]   [Full Text] [Related]  

  • 9. Combating COVID-19: The role of drug repurposing and medicinal plants.
    Khan SA; Al-Balushi K
    J Infect Public Health; 2021 Apr; 14(4):495-503. PubMed ID: 33743371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of repurposed antiviral drugs: Lessons from COVID-19.
    Martinez MA
    Drug Discov Today; 2022 Jul; 27(7):1954-1960. PubMed ID: 35192924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.
    Wattanakul T; Chotsiri P; Scandale I; Hoglund RM; Tarning J
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):945-958. PubMed ID: 36017624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repurposing: An Alternative Strategy to Treat COVID-19.
    Han P; Zheng H; Wen P; Pan L; Geng D; Sun D
    Curr Pharm Biotechnol; 2022; 23(6):818-827. PubMed ID: 34250872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
    Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
    Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational antiviral drugs for the treatment of COVID-19 patients.
    Beheshtirouy S; Khani E; Khiali S; Entezari-Maleki T
    Arch Virol; 2022 Mar; 167(3):751-805. PubMed ID: 35138438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of Chemotherapeutics to Combat COVID-19.
    Nandi S; Nayak BS; Khede MK; Saxena AK
    Curr Top Med Chem; 2022; 22(32):2660-2694. PubMed ID: 36453483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
    Jang WD; Jeon S; Kim S; Lee SY
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34234012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Repurposing of Drugs with Anti-SARS-CoV-2 Activity in Preclinical Trials: A Systematic Review.
    Rocha YM; de Moura GA; de Oliveira JR; de Figueiredo Nicolete LD; Nicolete R
    Curr Med Chem; 2021; 28(22):4577-4585. PubMed ID: 33019921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.
    Laws M; Surani YM; Hasan MM; Chen Y; Jin P; Al-Adhami T; Chowdhury M; Imran A; Psaltis I; Jamshidi S; Nahar KS; Rahman KM
    Curr Med Chem; 2021; 28(19):3803-3824. PubMed ID: 32693756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions.
    Shariare MH; Parvez MAK; Karikas GA; Kazi M
    J Infect Public Health; 2021 Feb; 14(2):214-220. PubMed ID: 33493917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.